NextVivo Analysis: $8M Raised
What is NextVivo?
Immune organoid technology for drug development
Location
Palo Alto, United States
Employees
1-10
Founded
2021
Product Features & Capabilities
- 3D organoid models of human tissues
- Immune competent human-derived models for drug testing
- Therapeutic applications for cancer, infections, and autoimmune disorders
Use Cases
Generate and test human-derived cell therapies; Develop antibody therapies against cancer; Recapitulate immune system defense mechanisms; Test therapies for autoimmune disorders; Model disease progression in human tissues
See something that needs updating? Suggest edits to this profile.